Atrys Health, S.A.
Stock Details
Is it expensive?
Market Cap
209.91M
Trailing P/E Ratio
--
Forward P/E Ratio
18.49
PEG Ratio
18.49
457.68M
72.79
Price-to-Sales (TTM)
1.50
1.42
2.00
Is it profitable?
144.31M
Net Profit Margin (TTM)
-69.50%
Gross Profit Margin
0.00%
Diluted EPS (TTM)
-0.73
-27.46%
Is it growing?
5.10%
0.00%
Is it risky?
0.56
169.70
257.87M
0.81
Who owns it?
5.57%
54.56%
0.00%
75.91M
42.54M
Does it pay?
0.00%
0.00%
--
--
How much cash?
13.58M
-1.56M
-129.51M
0.18
- Price (EOD)
- 2.77
- Percent Change
- -0.05 (1.60%)
- Previous Close
- 2.81
- Open
- 2.85
- Low
- 2.77
- High
- 2.87
52-Week Range Position (52WRP)
Below Average
Below Average
within its 1-year price range
€2.77
From 52W Low
+11.49%
From 52W High
-22.98%
Today
-1.60%
1Y Change
+3.17%
6M
€2.71
3M
€2.81
1M
€2.81
Today
€2.77
From 52W Low
+11.49%
From 52W High
-22.98%
Today
-1.60%
1Y Change
+3.17%
6M
€2.71
3M
€2.81
1M
€2.81
Today
€2.77
Below Average
within its 1-year price range
€2.77
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-1.6%
3M
-1.6%
6M
+2.0%
1Y
+3.2%
Rate of Change (ROC)
Insufficient price history
Relative Volume (RVOL)
Average
Volume is in line with the 90-day average. No unusual activity detected. Price moves on average volume carry less confirmation. As reflected in the Relative Volume (RVOL) below.
- Name
- Atrys Health, S.A.
- Founded
- 2007
- CEO
- Isabel Lozano Fernandez
- Employees
- 553
- Fiscal Year End
- Dec 31, 2025
- Address
Príncipe de Vergara 132
Madrid
MI
28002
Spain
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.atryshealth.com
Indicators
Operating Cash Flow
-1.56M
Net Income
-55.37M
Paper Profits
0.03
Company reports significant profit, but very little cash is actually coming in. This pattern has historically preceded earnings corrections and dividend cuts.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
IBEX Small CapIndex IBEX Small Cap - IBEXSC |
Indicators
Operating Cash Flow
-1.56M
Net Income
-55.37M
Paper Profits
0.03
Company reports significant profit, but very little cash is actually coming in. This pattern has historically preceded earnings corrections and dividend cuts.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Market Cap
209.91M
Trailing P/E Ratio
--
Forward P/E Ratio
18.49
PEG Ratio
18.49
457.68M
72.79
Price-to-Sales (TTM)
1.50
1.42
2.00
Is it profitable?
144.31M
Net Profit Margin (TTM)
-69.50%
Gross Profit Margin
0.00%
Diluted EPS (TTM)
-0.73
-27.46%
Is it growing?
5.10%
0.00%
Is it risky?
0.56
169.70
257.87M
0.81
Who owns it?
5.57%
54.56%
0.00%
75.91M
42.54M
Does it pay?
0.00%
0.00%
--
--
How much cash?
13.58M
-1.56M
-129.51M
0.18
- Price (EOD)
- 2.77
- Percent Change
- -0.05 (1.60%)
- Previous Close
- 2.81
- Open
- 2.85
- Low
- 2.77
- High
- 2.87
52-Week Range Position (52WRP)
Below Average
Below Average
within its 1-year price range
€2.77
From 52W Low
+11.49%
From 52W High
-22.98%
Today
-1.60%
1Y Change
+3.17%
6M
€2.71
3M
€2.81
1M
€2.81
Today
€2.77
From 52W Low
+11.49%
From 52W High
-22.98%
Today
-1.60%
1Y Change
+3.17%
6M
€2.71
3M
€2.81
1M
€2.81
Today
€2.77
Below Average
within its 1-year price range
€2.77
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-1.6%
3M
-1.6%
6M
+2.0%
1Y
+3.2%
Rate of Change (ROC)
Insufficient price history
Relative Volume (RVOL)
Average
Volume is in line with the 90-day average. No unusual activity detected. Price moves on average volume carry less confirmation. As reflected in the Relative Volume (RVOL) below.
- Name
- Atrys Health, S.A.
- Founded
- 2007
- CEO
- Isabel Lozano Fernandez
- Employees
- 553
- Fiscal Year End
- Dec 31, 2025
- Address
Príncipe de Vergara 132
Madrid
MI
28002
Spain
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.atryshealth.com
Related Heatmaps
IBEX Small CapIndex IBEX Small Cap - IBEXSC |